Atlas Trials

Fibrolamellar Carcinoma

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Fibrolamellar Carcinoma

RecordFirmDate
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer (NCT06521567)GlaxoSmithKline2025-03-06
Agnostic Therapy in Rare Solid Tumors (NCT06638931)Instituto do Cancer do Estado de São Paulo2024-07-16
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers (NCT06541652)Federation Francophone de Cancerologie Digestive2024-03-26
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients (NCT05468359)St. Jude Children's Research Hospital2022-11-07
KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) (NCT05603572)Primocure Pharma2022-11-01
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma (NCT04134559)Allison O'Neill, MD2020-11-01
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer (NCT03860272)Agenus Inc.2019-03-20
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery (NCT03533582)Children's Oncology Group2018-05-24
Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT02159989)National Cancer Institute (NCI)2014-06-18
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) (NCT01642186)Memorial Sloan Kettering Cancer Center2012-07-12

Track Fibrolamellar Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.